Julio Rosenstock

The University of Texas Southwestern Medical Center

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100”.

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100

Diabetes Care(2021)10.2337/dc20-2878

N/A

4.7DataRank · unranked

96 citations

John B. Buse, Edward Franek, M. Hansen, Mette Koefoed, Chantal Mathieu +4 more

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Diabetes Care(2020)10.2337/dc20-0279

N/A

1.9DataRank · unranked

61 citations

Robert D. Toto, Mark E. Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire +12 more

Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.03.380

N/A

0.980DataRank · unranked

26 citations

Javed Butler, Stefano Del Prato, Justin A. Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam +8 more

Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial

Circulation(2023)10.1161/circulationaha.122.063716

N/A

0.901DataRank · unranked

25 citations

Zhuoru Li, Chinthanie Ramasundarahettige, Seung Jae Baek, Kelley R. Branch, Stefano Del Prato +6 more

Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad298

N/A

0.641DataRank · unranked

11 citations

Julio Rosenstock, Takuji Kohzuma, Vivian Fonseca, Cyrus Desouza

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf022

N/A

0.532DataRank · unranked

22 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl +94 more

Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes

Diabetes Care(2025)10.2337/dc24-2841

N/A

0.510DataRank · unranked

29 citations

Steven E. Kahn, Vanita R. Aroda, Richard J. Auchus, Timothy S. Bailey, Irina Bancos +79 more

Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf160

N/A

0.253DataRank · unranked

4 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Sung Gyun Kim, Johannes F.E. Mann, Janet B. McGill +10 more

Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial

Diabetes Obesity and Metabolism(2023)10.1111/dom.14991

N/A

0.241DataRank · unranked

4 citations

Ahmed A. Kolkailah, Darren K. McGuire, Mark A. Espeland, Michaela Mattheus, Egon Pfarr +4 more

Prevalence of Hypercortisolism in Patients with Difficult-to-control Type 2 Diabetes: Final Results from CATALYST Part 1

Metabolism(2025)10.1016/j.metabol.2025.156211

N/A

0DataRank · unranked

0 citations

Steven E. Kahn, Vanita R. Aroda, Richard J. Auchus, Timothy S. Bailey, Irina Bancos +21 more

Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST

Metabolism(2025)10.1016/j.metabol.2025.156214

N/A

0DataRank · unranked

0 citations

Vanita R. Aroda, Timothy S. Bailey, Robert S. Busch, John B. Buse, Elena A. Christofides +17 more

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum

UNC Libraries(2020)10.17615/vfet-4c91

N/A

0DataRank · unranked

0 citations

Alexander Fleming, Ele Ferrannini, William T. Cefalu, Hertzel C. Gerstein, Ambady Ramachandran +6 more

Effect of Efpeglenatide on Heart Failure Outcomes: A Participant-Level Exploratory Analysis of the Randomized AMPLITUDE-O Trial

Diabetes Care(2025)10.2337/dc24-2629

N/A

0DataRank · unranked

0 citations

Carolyn S.P. Lam, Shofiqul Islam, Stefano Del Prato, Renato D. Lópes, Richard E. Pratley +4 more

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

UNC Libraries(2020)10.17615/4vwj-jv12

N/A

0DataRank · unranked

0 citations

Arthur Sands, Phillip Banks, Paul Strumph, Bruce W. Bode, John B. Buse +7 more

Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

Nature Medicine(2022)10.1038/s41591-022-02011-x

N/A

0DataRank · unranked

57 citations

Schafer Boeder, Mark P. Christiansen, Douglas Denham, Timothy S. Bailey, Halis Kaan Aktürk +11 more

Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial

Clinical Kidney Journal(2020)10.1093/ckj/sfaa225

N/A

0DataRank · unranked

18 citations

Mark E. Cooper, Odd Erik Johansen, Robert D. Toto, Julio Rosenstock, Darren K. McGuire +12 more

Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment

Diabetes Care(2025)10.2337/dc25-1055

N/A

0DataRank · unranked

17 citations

Vivian Fonseca, Vanita R. Aroda, Richard J. Auchus, Timothy S. Bailey, Irina Bancos +78 more

Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and Cardiovascular Disease: Results from CATALYST

Metabolism(2025)10.1016/j.metabol.2025.156212

N/A

0DataRank · unranked

0 citations

Vanita R. Aroda, Matthew J. Budoff, Robert S. Busch, John B. Buse, Ralph A. DeFronzo +13 more